MX2018009912A - Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina. - Google Patents

Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina.

Info

Publication number
MX2018009912A
MX2018009912A MX2018009912A MX2018009912A MX2018009912A MX 2018009912 A MX2018009912 A MX 2018009912A MX 2018009912 A MX2018009912 A MX 2018009912A MX 2018009912 A MX2018009912 A MX 2018009912A MX 2018009912 A MX2018009912 A MX 2018009912A
Authority
MX
Mexico
Prior art keywords
pyrrolo
preparing
pyrimidine compounds
methyl
methanesulfonamide
Prior art date
Application number
MX2018009912A
Other languages
English (en)
Inventor
Lee Stuk Timothy
Billen Denis
Sue Westrick Valerie
Warnajith Liyana Gunawardana Vageesha
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2018009912A publication Critical patent/MX2018009912A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/19—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente se describen procesos mejorados para la preparacion del compuesto de 7H-pirrolo[2,3-d]pirimidina, N-metil-1-{trans-4-[metil(7H-pirrolo[2,3-d]pirimidin-4-il)amino]c iclohexil}-metanosulfonamida, intermedios de estos y sales veterinariamente aceptables de estos (Formula (1)).
MX2018009912A 2016-02-16 2017-02-07 Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina. MX2018009912A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662295739P 2016-02-16 2016-02-16
US201662375040P 2016-08-15 2016-08-15
PCT/US2017/016778 WO2017142740A1 (en) 2016-02-16 2017-02-07 Process for preparing 7h-pyrrolo [2, 3-d] pyrimidine compounds

Publications (1)

Publication Number Publication Date
MX2018009912A true MX2018009912A (es) 2018-11-29

Family

ID=58018338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009912A MX2018009912A (es) 2016-02-16 2017-02-07 Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina.

Country Status (15)

Country Link
US (1) US9926327B2 (es)
EP (1) EP3416965B1 (es)
JP (1) JP6568324B2 (es)
KR (1) KR102124449B1 (es)
CN (1) CN108699072B (es)
AU (1) AU2017221193B2 (es)
BR (1) BR112018016708B1 (es)
CA (1) CA3012589C (es)
CL (1) CL2018002344A1 (es)
CO (1) CO2018008253A2 (es)
MX (1) MX2018009912A (es)
NZ (1) NZ744341A (es)
RU (1) RU2699034C1 (es)
WO (1) WO2017142740A1 (es)
ZA (1) ZA201804871B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2022471B1 (en) * 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib
AU2019426113B2 (en) * 2019-01-30 2022-06-16 Felicamed Biotechnology Co., Ltd. JAK inhibitor and preparation method therefor
CA3152021A1 (en) * 2019-08-26 2021-03-04 Chemwerth, Inc. Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors
CN112279854B (zh) * 2020-08-25 2022-04-05 常州齐晖药业有限公司 一种7H-吡咯并[2,3-d]嘧啶化合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424213A (en) 1980-11-10 1984-01-03 Sds Biotech Corporation Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
AU3951899A (en) 1998-06-19 2000-01-05 Pfizer Products Inc. Pyrrolo(2,3-d)pyrimidine compounds
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
US8193206B2 (en) 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
KR100987870B1 (ko) 2005-07-29 2010-10-13 화이자 프로덕츠 인코포레이티드 피롤로[2,3-ｄ]피리미딘 유도체, 이들의 중간체 및 합성
CA2733359C (en) * 2008-08-20 2014-08-05 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
KR20120083452A (ko) * 2009-10-15 2012-07-25 화이자 인코포레이티드 피롤로［2,3-ｄ］피리미딘 화합물
ES2461967T3 (es) * 2009-12-18 2014-05-21 Pfizer Inc. Compuestos de pirrolo[2,3-d]pirimidina
MX2012009798A (es) * 2010-02-24 2012-09-12 Pfizer Composiciones veterinarias.

Also Published As

Publication number Publication date
EP3416965A1 (en) 2018-12-26
KR20180100225A (ko) 2018-09-07
BR112018016708B1 (pt) 2023-11-07
RU2699034C1 (ru) 2019-09-03
CN108699072B (zh) 2021-02-26
CA3012589C (en) 2020-05-05
AU2017221193A1 (en) 2018-08-09
NZ744341A (en) 2019-06-28
CN108699072A (zh) 2018-10-23
JP6568324B2 (ja) 2019-08-28
CO2018008253A2 (es) 2018-08-21
BR112018016708A2 (pt) 2018-12-26
ZA201804871B (en) 2019-05-29
US9926327B2 (en) 2018-03-27
AU2017221193B2 (en) 2019-03-14
KR102124449B1 (ko) 2020-06-26
JP2019505547A (ja) 2019-02-28
US20170233397A1 (en) 2017-08-17
CA3012589A1 (en) 2017-08-24
WO2017142740A1 (en) 2017-08-24
EP3416965B1 (en) 2020-10-07
CL2018002344A1 (es) 2018-09-14

Similar Documents

Publication Publication Date Title
PH12019500930A1 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF
PH12018500437A1 (en) Novel pyrazolo [3,4-d] pyrimidine compounds or salt thereof
CO2018008253A2 (es) Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina
MX2019012927A (es) Sales del inhibidor fosfoinositida 3-cinasa (pi3k) y procesos para su preparacion.
PH12018501643A1 (en) Tlr7 agonist crystalline form a, preparation method and use thereof
NZ722624A (en) Fused pyrimidines as inhibitors of p97 complex
NZ727996A (en) Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncytial virus infections
WO2016063294A3 (en) Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
MX2017016772A (es) Metodo para producir un derivado de 7h-pirrolo[2,3-d]pirimidina e intermediario del mismo.
PH12018501641B1 (en) Tlr7 agonist trifluoroacetate salt and crystalline form b thereof, preparation methods and uses
MX2020012097A (es) Proceso para preparar inhibidores de tirosina cinasa de bruton (btk).
MX2017015837A (es) Procesos e intermediarios para la preparacion de {1-(etilsulfonil)-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-piraz ol-1-il]azetidin-3-il}acetonitrilo.
NZ728707A (en) 2’-chloro aminopyrimidinone and pyrimidine dione nucleosides
MX2018013133A (es) Compuesto de pirazolo[1,5-a]pirimidina.
PH12018501642B1 (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
IL288080A (en) A process for the preparation of h7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates
WO2015110491A3 (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof
PH12018502246A1 (en) Substituted fused pyrimidinone compounds
MX2020008110A (es) Sal de compuesto de pirazolo[1,5-a]pirimidina y cristales de la misma.
MX2017008430A (es) Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.
CU20190035A7 (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina
UA80534U (uk) 1-[[3-(4,7-ДИГІДРО-1-МЕТИЛ-7-ОКСО-3-ПРОПІЛ-1Н-ПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ІЛ)-4-ЕТОКСИФЕНІЛ]СУЛЬФОНІЛ]-4-МЕТИЛПІПЕРАЗИН ТА ЙОГО ФАРМАЦЕВТИЧНО ПРИЙНЯТНІ СОЛІ

Legal Events

Date Code Title Description
FG Grant or registration